Toll Free : + 1-888-961-4454 | Int'l : + 91 (788) 802-9103 | support@researchdive.com
LI23018597 |
Pages: 200 |
Jan 2023 |
Asthma is the most common non-communicable disease in children and one of the most common chronic diseases in adulthood. It is a major global health problem. People with asthma have chronic inflammation in their airways. During an asthma attack, the smooth muscle that lines the lungs swells even more. People in the 30 to 50 age group who have severe asthma choose bronchial thermoplasty as the best treatment option as per advice by specialists. This has resulted in the growth of the bronchial thermoplasty catheter market globally. Bronchial thermography (BT) reduces ASM (airway smooth muscle) and relieves symptoms in this treatment. Additionally, the asthma patients' quality of life is enhanced by BT because it reduces ASM (Airway Smooth Muscle), bronchoconstriction, and asthma exacerbations. Three sessions are required for bronchial thermoplasty treatment, each separated by at least three weeks. The right lower lobe of airways is treated in the first session, the left lower lobe in the second, and then both upper lobes in the third. Increasing geriatric population and growing number of hospitals are two major growth drivers for this market.
The bronchial thermoplasty treatment has some possible side effects that might come after the procedure such as chest tightness and wheezing. People may experience a brief wheezing problem after the treatment, but it typically resolves within a week. The bronchial thermoplasty catheter market growth is expected to be hampered by these side effects of bronchial thermoplasty treatment.
Bronchial thermoplasty is an outpatient procedure that treats severe asthma by addressing it at the source. It utilizes a probe that generates heat and causes scarred, thickened lung tissue to shrink. Bronchial thermoplasty has been shown to reduce asthma attacks for at least 5 years. The increase in the rate of asthma, as well as the rise in pollution and dust allergy problems, are the primary opportunity for the bronchial thermoplasty industry. Additionally, the growth rate of the bronchial thermoplasty catheter market share will be significantly affected by the growing number of government initiatives to raise public awareness. Advancements in technology is another important opportunity to the growth of the market.
Region-wise, the North America bronchial thermoplasty catheter market accounted a dominating market share in 2021. Increasing asthma attacks among individuals, increase in the number of hospitalizations of asthma patients in the U.S, the presence of major players in the region, and rapid technological advancements are some of the factors that have contributed to the growth of the bronchial thermoplasty market in the North America region.
Bronchial thermoplasty is a treatment option for asthma patients that helps to avoid persistent structural alterations in the airway smooth muscle (ASM). Bronchial thermoplasty is an asthma treatment that targets the smooth muscle in the lungs as well as bronchoconstriction and asthma exacerbations, improving an asthma patient's quality of life. Bronchial thermoplasty enables the precise delivery of radiofrequency radiation to the airway wall through a dedicated catheter.
The COVID-19 pandemic negatively impacted the bronchial thermoplasty catheter market as hospitalization rate for asthma cases decreased during the COVID-19 pandemic and only for severe illnesses, patients were admitted to the hospitals. Also, there are very few companies in the market that offer bronchial thermoplasty catheters. In addition, COVID-19 virus majorly impacts the respiratory system. Hence, patients diagnosed with COVID-19 were hospitalized for its treatment and asthma-related hospitalizations were declined. As bronchial thermoplasty catheter system is used to treat patients with severe asthma, its demand decreased during the pandemic. Asthmatic patients must remain cautious throughout the COVID-19 pandemic, taking all steps to stay safe. A deeper knowledge of asthmatic exacerbation and its connection to COVID-19 should be part of future initiatives. Because of this new condition, healthcare services had to adjust, including reallocating people and supplies as well as changing management standards. A significant problem is to avoid exposing patients and healthcare personnel to the danger of infection and act on increasing the availability of personal protective equipment.
Airway remodeling in severe asthma comprises increase in airway smooth muscle mass, which is linked with reduced lung function, airway hyper responsiveness, and poor symptom management. Bronchial thermoplasty lowers the quantity of airway smooth muscle in experimental animals, patients with bronchial cancer awaiting lung resection, and people with asthma. There is contradictory evidence about whether reduced airway smooth muscle mass is connected with improved clinical outcomes following bronchial thermoplasty catheters.
Increasing pollution is hazardous to asthma patients because dust mites damage the health of those with asthma and those who are allergic or sensitive to mites. These allergens can cause mild to severe allergic reactions and asthma attacks. Most people prefer a bronchial thermoplasty catheter procedure for asthma disease recovery.
To know more about global bronchial thermoplasty catheter market drivers, get in touch with our analysts here.
As a therapy for people with severe asthma, bronchial thermoplasty may be provided, and it works effectively for asthma patients. Bronchial thermoplasty (BT) is a new therapeutic option for people with asthma who have not responded to standard medication. BT is an intrusive technique that can cause coughing, wheezing, bronchospasm, and laryngospasm both, during and after the operation. The important challenges to BT services are a lack of bronchial thermoplasty service providers in rural and urban areas and a shortage of skilled workers. Rural populations face a variety of challenges when it comes to healthcare services, making it difficult for them to receive the treatment they need. The healthcare industry's growth is hampered by a number of factors, including the high cost of bronchial thermoplasty catheter services. The primary impediment to the bronchial thermoplasty catheter market revenue growth is a lack of skilled professionals as a result of a lack of relevant skills.
Asthma incidence has risen in tandem with the frequency of other allergens, such as allergic rhinitis and eczema. Asthma incidence and prevalence patterns differ between children and adults. Asthma commonly begins in childhood; however, it can occur at any age, with some people experiencing asthma for the first time as adults. Prepubertal males have a higher incidence, prevalence, and hospitalization rate for asthma than prepubertal females. This pattern may reverse through adolescence. Additionally, the need for bronchial thermoplasty catheter services is growing significantly as the elderly population increases. To ensure that the elderly population receives end-to-end bronchial thermoplasty catheters, service providers concentrate on all aspects of hospital settings. For instance, in August 2021 the U.S. Food and Drug Administration (FDA) approved the Boston Scientific Corporation EXALT Model B Single-Use Bronchoscope, which is designed to treat wide range of bronchoscopy procedure such as airway intubation, secretion management, percutaneous tracheostomy, double lumen endotracheal tube placement and biopsies.
To know more about global bronchial thermoplasty catheter market opportunities, get in touch with our analysts here.
By end user, the market has been divided into hospitals and ambulatory surgery centers. Among these, the ambulatory surgery centers segment accounted for the highest market share in 2021 whereas the hospitals segment is estimated to show the fastest growth during the forecast period.
Source: Research Dive Analysis
The ambulatory surgery centers segment accounted a dominant market share in 2021. Ambulatory surgery centers (ASCs) are medical clinics that specialize in outpatient surgical services. Outpatient refers to a patient who is not admitted to a hospital and may leave on the same day of the surgery. Patients who choose to have surgery in an ASC arrive on the day of the procedure, have the surgery in a fully equipped operating room, and recover under the supervision of highly competent nurses, all without the need for hospitalization. Patients and their families benefit from the comfortable environment provided by ASCs, whether patients are young, elderly, or somewhere in between.
The hospitals segment is anticipated to show the fastest growth by 2031. Greater healthcare substructure, the availability of a skilled workforce, and the cost-effectiveness of the materials used to make catheters are all reasons that are causing this market to grow. Another factor that influenced the growth of the bronchial thermoplasty catheter market is a significant growth in the geriatric population suffering from unhealthy lifestyles including asthma, which is expected to boost the growth of hospital segment.
The bronchial thermoplasty catheter market was analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Source: Research Dive Analysis
The North America bronchial thermoplasty catheter market size accounted a dominating market share in 2021. The demand for bronchial thermoplasty catheter in the North America region is rising due to use of automobiles as well as government rules for reducing vehicle accidents, which is creating opportunities for the bronchial thermoplasty industry. Increasing asthma attacks among individuals, increase in the number of hospitalizations of asthma patients in the U.S., the presence of major players, and rapid technological advancements are some of the factors that have contributed to the growth of the bronchial thermoplasty market in the North American region. Because of its high adoption of technically advanced treatment devices and processes, North America is expected to have the largest share of the global market during the forecast period. Even though this is a new method, a large number of public and commercial healthcare payers are considering reimbursement for these treatments on a case-by-case basis. These factors are increasing the development of bronchial thermoplasty catheter in region
Investment and agreement are common strategies followed by major market players. For instance, Boston Scientific Corporation acquired Asthmatx, Inc., a manufacturer of the Alair system, in 2010. This system was approved by the FDA in the U.S. in April 2010 and by the CE Mark in 2011.
Source: Research Dive Analysis
Currently Boston Scientific is the only manufacturing company in the bronchial thermoplasty catheter market.
| Aspect | Particulars |
| Historical Market Estimations | 2020 |
| Base Year for Market Estimation | 2020-2021 |
| Forecast Timeline for Market Projection | 2022-2031 |
| Geographical Scope | North America, Europe, Asia-Pacific, and LAMEA |
| Segmentation by End User |
|
| Key Companies Profiled |
|
1.Research Methodology
1.1.Desk Research
1.2.Real time insights and validation
1.3.Forecast model
1.4.Assumptions and forecast parameters
1.5.Market size estimation
1.5.1.Top-down approach
1.5.2.Bottom-up approach
2.Report Scope
2.1.Market definition
2.2.Key objectives of the study
2.3.Report overview
2.4.Market segmentation
2.5.Overview of the impact of COVID-19 on Global Bronchial Thermoplasty Catheter Market
3.Executive Summary
4.Market Overview
4.1.Introduction
4.2.Growth impact forces
4.2.1.Drivers
4.2.2.Restraints
4.2.3.Opportunities
4.3.Market value chain analysis
4.3.1.List of raw material suppliers
4.3.2.List of manufacturers
4.3.3.List of distributors
4.4.Innovation & sustainability matrices
4.4.1.Technology matrix
4.4.2.Regulatory matrix
4.5.Porter’s five forces analysis
4.5.1.Bargaining power of suppliers
4.5.2.Bargaining power of consumers
4.5.3.Threat of substitutes
4.5.4.Threat of new entrants
4.5.5.Competitive rivalry intensity
4.6.PESTLE analysis
4.6.1.Political
4.6.2.Economical
4.6.3.Social
4.6.4.Technological
4.6.5.Environmental
4.7.Impact of COVID-19 on Bronchial Thermoplasty Catheter Market
4.7.1.Pre-covid market scenario
4.7.2.Post-covid market scenario
5.Bronchial Thermoplasty Catheter Market Analysis, by End User
5.1.Overview
5.2.Hospitals
5.2.1.Definition, key trends, growth factors, and opportunities
5.2.2.Market size analysis, by region, 2021-2031
5.2.3.Market share analysis, by country, 2021-2031
5.3.Ambulatory Surgery Centers
5.3.1.Definition, key trends, growth factors, and opportunities
5.3.2.Market size analysis, by region, 2021-2031
5.3.3.Market share analysis, by country, 2021-2031
5.4.Research Dive Exclusive Insights
5.4.1.Market attractiveness
5.4.2.Competition heatmap
6.Bronchial Thermoplasty Catheter Market, by Region
6.1.North America
6.1.1.U.S.
6.1.1.1.Market size analysis, by End User
6.1.2.Canada
6.1.2.1.Market size analysis, by End User
6.1.3.Mexico
6.1.3.1.Market size analysis, by End User
6.1.4.Research Dive Exclusive Insights
6.1.4.1.Market attractiveness
6.1.4.2.Competition heatmap
6.2.Europe
6.2.1.Germany
6.2.1.1.Market size analysis, by End User
6.2.2.UK
6.2.2.1.Market size analysis, by End User
6.2.3.France
6.2.3.1.Market size analysis, by End User
6.2.4.Spain
6.2.4.1.Market size analysis, by End User
6.2.5.Italy
6.2.5.1.Market size analysis, by End User
6.2.6.Rest of Europe
6.2.6.1.Market size analysis, by End User
6.2.7.Research Dive Exclusive Insights
6.2.7.1.Market attractiveness
6.2.7.2.Competition heatmap
6.3.Asia-Pacific
6.3.1.China
6.3.1.1.Market size analysis, by End User
6.3.2.Japan
6.3.2.1.Market size analysis, by End User
6.3.3.India
6.3.3.1.Market size analysis, by End User
6.3.4.Australia
6.3.4.1.Market size analysis, by End User
6.3.5.South Korea
6.3.5.1.Market size analysis, by End User
6.3.6.Rest of Asia-Pacific
6.3.6.1.Market size analysis, by End User
6.3.7.Research Dive Exclusive Insights
6.3.7.1.Market attractiveness
6.3.7.2.Competition heatmap
6.4.LAMEA
6.4.1.Brazil
6.4.1.1.Market size analysis, by End User
6.4.2.Saudi Arabia
6.4.2.1.Market size analysis, by End User
6.4.3.UAE
6.4.3.1.Market size analysis, by End User
6.4.4.South Africa
6.4.4.1.Market size analysis, by End User
6.4.5.Rest of LAMEA
6.4.5.1.Market size analysis, by End User
6.4.6.Research Dive Exclusive Insights
6.4.6.1.Market attractiveness
6.4.6.2.Competition heatmap
7.Competitive Landscape
7.1.Top winning strategies, 2021
7.1.1.By strategy
7.1.2.By year
7.2.Strategic overview
7.3.Market share analysis, 2021
8.Company Profiles
8.1.Boston Scientific
8.1.1.Overview
8.1.2.Business segments
8.1.3.Product portfolio
8.1.4.Financial performance
8.1.5.Recent developments
8.1.6.SWOT analysis
9.Appendix
9.1.Parent & peer market analysis
9.2.Premium insights from industry experts
9.3.Related reports
* Taxes/Fees, If applicable will be added during checkout. All prices in USD.
Have a question ?
Enquire To BuyNeed to add more ?
Request Customization
